These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 7064884

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Protein and leucine metabolism in maple syrup urine disease.
    Thompson GN, Bresson JL, Pacy PJ, Bonnefont JP, Walter JH, Leonard JV, Saudubray JM, Halliday D.
    Am J Physiol; 1990 Apr; 258(4 Pt 1):E654-60. PubMed ID: 2185648
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A new variety of maple syrup urine disease.
    Harkness RA, Cockburn F, Grant M, Giles MM, Turner TL, Darling JA.
    Ann Clin Biochem; 1977 May; 14(3):146-8. PubMed ID: 869494
    [No Abstract] [Full Text] [Related]

  • 6. [Methodology of care for children with phenylketonuria and maple-syrup urine disease].
    Jiménez Soto Z.
    Arch Latinoam Nutr; 1993 Sep; 43(3):204-10. PubMed ID: 8779621
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Transaminations between amino acids and keto acids elevated in phenylketonuria and maple syrup urine disease.
    Lees GJ, Weiner N.
    J Neurochem; 1973 Feb; 20(2):389-403. PubMed ID: 4698286
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Control of pyruvate and beta-hydroxybutyrate utilization in rat brain mitochondria and its relevance to phenylketonuria and maple syrup urine disease.
    Land JM, Mowbray J, Clark JB.
    J Neurochem; 1976 Apr; 26(4):823-30. PubMed ID: 987160
    [No Abstract] [Full Text] [Related]

  • 13. Acute illness in maple syrup urine disease: dynamics of protein metabolism and implications for management.
    Thompson GN, Francis DE, Halliday D.
    J Pediatr; 1991 Jul; 119(1 Pt 1):35-41. PubMed ID: 2066856
    [Abstract] [Full Text] [Related]

  • 14. [Experiences with a new amino acid analyzer for a rapid analysis].
    Irtel von Brenndorff A, Hagge W.
    Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):417-9. PubMed ID: 5523694
    [No Abstract] [Full Text] [Related]

  • 15. Effect of insulin on leucine kinetics in maple syrup urine disease.
    Collins JE, Umpleby AM, Boroujerdi MA, Leonard JV, Sonksen PH.
    Pediatr Res; 1987 Jan; 21(1):10-3. PubMed ID: 3540829
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Whole-body L-leucine oxidation in patients with variant form of maple syrup urine disease.
    Schadewaldt P, Bodner-Leidecker A, Hammen HW, Wendel U.
    Pediatr Res; 2001 May; 49(5):627-35. PubMed ID: 11328944
    [Abstract] [Full Text] [Related]

  • 18. A rapid ultra performance liquid chromatography tandem mass spectrometric method for measuring amino acids associated with maple syrup urine disease, tyrosinaemia and phenylketonuria.
    Freeto S, Mason D, Chen J, Scott RH, Narayan SB, Bennett MJ.
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):474-81. PubMed ID: 17761035
    [Abstract] [Full Text] [Related]

  • 19. Serum-selenium concentrations in patients with maple-syrup-urine disease and phenylketonuria under dieto-therapy.
    Lombeck I, Kasperek K, Feinendegen LE, Bremer HJ.
    Clin Chim Acta; 1975 Oct 01; 64(1):57-61. PubMed ID: 1183026
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.